Kevin Gordon

Mr. Gordon joined Kohlberg in 2023 as an Operating Executive. He serves on the board of directors of Worldwide Clinical Trials and currently serves on the boards of Progyny, Inc. and Q Holdco Limited, providing operating and governance experience across healthcare services organizations. Previously, Mr. Gordon served as Executive Vice President and Chief Operating Officer, and Executive Vice President and Chief Financial Officer of Quintiles Transnational (now IQVIA), President and Chief Financial Officer of Liquidia Technologies, Inc., and Executive Vice President and Chief Financial Officer of Teleflex Incorporated. He served as a director at Veracyte, Inc., Sanisure, LLC and Cirtec Medical Corporation. Mr. Gordon began his career at KPMG after earning a B.S. in Accounting from the University of Connecticut.